These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28710692)

  • 1. Host Factors Involved in Ebola Virus Replication.
    Rasmussen AL
    Curr Top Microbiol Immunol; 2018; 419():113-150. PubMed ID: 28710692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion.
    Pleet ML; DeMarino C; Stonier SW; Dye JM; Jacobson S; Aman MJ; Kashanchi F
    Viruses; 2019 May; 11(5):. PubMed ID: 31052499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Transcriptional Changes within Liver, Adrenal Gland, and Lymphoid Tissues Significantly Contribute to Ebola Virus Pathogenesis in Cynomolgus Macaques.
    Jankeel A; Menicucci AR; Woolsey C; Fenton KA; Mendoza N; Versteeg K; Cross RW; Geisbert TW; Messaoudi I
    J Virol; 2020 May; 94(11):. PubMed ID: 32213610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional Analysis of Lymphoid Tissues from Infected Nonhuman Primates Reveals the Basis for Attenuation and Immunogenicity of an Ebola Virus Encoding a Mutant VP35 Protein.
    Pinski A; Woolsey C; Jankeel A; Cross R; Basler CF; Geisbert T; Messaoudi I
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host Factors in Ebola Infection.
    Rasmussen AL
    Annu Rev Genomics Hum Genet; 2016 Aug; 17():333-51. PubMed ID: 27147086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK Cells Accumulate in Infected Tissues and Contribute to Pathogenicity of Ebola Virus in Mice.
    Fausther-Bovendo H; Qiu X; He S; Bello A; Audet J; Ippolito G; Wong G; Kobinger G
    J Virol; 2019 May; 93(10):. PubMed ID: 30814283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune evasion in ebolavirus infections.
    Audet J; Kobinger GP
    Viral Immunol; 2015 Feb; 28(1):10-8. PubMed ID: 25396298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells.
    Hoffmann M; Nehlmeier I; Brinkmann C; Krähling V; Behner L; Moldenhauer AS; Krüger N; Nehls J; Schindler M; Hoenen T; Maisner A; Becker S; Pöhlmann S
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development.
    Zhu W; Banadyga L; Emeterio K; Wong G; Qiu X
    Viruses; 2019 Oct; 11(11):. PubMed ID: 31683550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin B & L are not required for ebola virus replication.
    Marzi A; Reinheckel T; Feldmann H
    PLoS Negl Trop Dis; 2012; 6(12):e1923. PubMed ID: 23236527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication.
    Bharaj P; Atkins C; Luthra P; Giraldo MI; Dawes BE; Miorin L; Johnson JR; Krogan NJ; Basler CF; Freiberg AN; Rajsbaum R
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28679761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A GXXXA Motif in the Transmembrane Domain of the Ebola Virus Glycoprotein Is Required for Tetherin Antagonism.
    González-Hernández M; Hoffmann M; Brinkmann C; Nehls J; Winkler M; Schindler M; Pöhlmann S
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 14. Ebola virus: unravelling pathogenesis to combat a deadly disease.
    Hoenen T; Groseth A; Falzarano D; Feldmann H
    Trends Mol Med; 2006 May; 12(5):206-15. PubMed ID: 16616875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity of Disease in Humanized Mice Infected With Ebola Virus or Reston Virus Is Associated With Magnitude of Early Viral Replication in Liver.
    Spengler JR; Saturday G; Lavender KJ; Martellaro C; Keck JG; Nichol ST; Spiropoulou CF; Feldmann H; Prescott J
    J Infect Dis; 2017 Dec; 217(1):58-63. PubMed ID: 29087482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Interleukin 1 Receptor Antagonist Enhances Susceptibility to Ebola Virus Infection.
    Hill-Batorski L; Halfmann P; Marzi A; Lopes TJ; Neumann G; Feldmann H; Kawaoka Y
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S329-35. PubMed ID: 26209680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ebola Immunity: Gaining a Winning Position in Lightning Chess.
    Ploquin A; Zhou Y; Sullivan NJ
    J Immunol; 2018 Aug; 201(3):833-842. PubMed ID: 30038036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental Respiratory Infection of Marmosets (Callithrix jacchus) With Ebola Virus Kikwit.
    Smither SJ; Nelson M; Eastaugh L; Nunez A; Salguero FJ; Lever MS
    J Infect Dis; 2015 Oct; 212 Suppl 2():S336-45. PubMed ID: 26209682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and pathobiology of Ebolavirus infection.
    Ansari AA
    J Autoimmun; 2014 Dec; 55():1-9. PubMed ID: 25260583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring Innate Immune Gene Responses in the Hamster Model of Ebola Virus Disease by RT-PCR.
    Zivcec M
    Methods Mol Biol; 2017; 1628():321-337. PubMed ID: 28573632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.